mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.44 |
0.02 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |